Cancer is a major contributor to global mortality, causing about 1 in every 6 deaths and affecting nearly every household. Globally, there were an estimated 20 million new cases of cancer and 9.7 million deaths from cancer in 2022. The cancer burden will increase by about 77% by 2050, further straining health systems, people, and communities.

In the WHO Eastern Mediterranean Region alone, more than 788,000 people were diagnosed with cancer in 2022. This number is projected to double to reach 1.57 million cases by 2045, because of population growth and, more importantly, the high prevalence of cancer risk factors in the Region – such as tobacco use, obesity/overweight, physical inactivity, unhealthy diets, and air pollution.

Cancer can also develop because of some infections, including hepatitis B and C (which affect the liver) or human papillomavirus (HPV, which affects the uterus). These infections are still very much present in the Eastern Mediterranean Region, even though hepatitis B and HPV can be easily prevented through vaccination.

Globally, the most common cancers are breast, lung, colon rectum, and prostate cancer. In 2020, breast cancer was the most prevalent cancer globally, while lung cancer led to the highest number of deaths.

Mammography (for breast cancer), colonoscopy (colorectal cancer), and Papanicolaou (Pap) smear (cervical cancer) are the most common and effective screening tests. Ask your family doctor for more details about your screening options.

The World Cancer Day 2025’s campaign “UNITED BY UNIQUE” IS about placing people at the centre of cancer care. United in our goals, unique in our needs. That is the World Cancer Day credo that will be heard around the world in the lead up to and on 4 February 2025.

The brain storming scientific sessions of the International Pharmacy Workshop (7th IPW) – 2025, will highlight the need to focus on New Research and Innovative Development of Anticancer drug therapy.”

 7th International Pharmacy Workshop (IPW) – World Cancer Day

6th Feb 2025

This workshop is focused on the current development of cancer medicines and modern therapies, with the theme Theme “Recent Progress in Diagnosis and Treatment of Cancer”

The Organizing Faculty: Faculty of Pharmacy The Partner University: Hawler Medical University, Qatar University, UKH, AmrLab, and Takvin
Date(s) of the Event: 6th Feb 2025 Venue of the Event:

Educational building, 302 Hall, Faculty of Pharmacy

The Main Sponsor: AmrLab Medical Laboratories and Takvin
Event Agenda
Date Hour Event
 

6TH Feb 2025

09.00 – 09.30 Registration
09.30- 09.40 Opening Ceremony at Faculty of Pharmacy
09.40- 09.45 Introducing the Event
09.45- 09.55 National Anthem both
09.55- 10.05 Promotional Videos
10.05 – 10.20 Welcome Speech by Assistant Prof. Dr. Idris Hadi, Head of Board of Trustees
10.05 – 10.20  Welcome Speech by Prof. Dr. Sultan Abu Orabi the President, Tishk International University                   
10.20- 10.25 Opening Address by Dr. Abdul Samad Salahuddin, Dean of Pharmacy Faculty, Tishk International University
10.25- 11.00 Keynote Speech I: Dr. Luqman Rahman, College of Medicine Hawler Medical University.

Title: Harnessing the power of immunotherapy in cancer treatment: Recent advances and future perspectives

11.00 – 11.25 Speaker-1 Dr. Suzan Hoshyar oncologist

Director of Breast Center Adjunct faculty at UKH

Title: Cancer Awareness

11.25 – 11.50 Speaker-2 Dr. Fahad Abdulwahab Jameel

Hematopathologist, University of Duhok, AmrLab Medical Laboratories.

Title: Delivery of Advanced Hemato-oncological Lab Tests to Those in Need: Creativity, Communication, Collaboration

11.50 – 12.00 Coffee Break
12.00 – 12.25 Online -Keynote Speech II: Dr. Amin Malik Shah Abdul Majid, Eman Research Ltd, Malaysia

Title: Botanical Drug For Cancer Therapy.

12.25 – 01.10 Online -Keynote Speech III: Dr. Hassaan A. Rathore, PhD

Associate Professor of Pharmaceutical Sciences

College of Pharmacy, Qatar University

Title: Molecular mechanisms in lung adenocarcinoma.

01.10 – 01-25 Closing Ceremony and Lunch
Name of the Speaker:   Dr. Luqman Rahman

Job Title of the Speaker: Senior Lecturer and Physician

Keynote Speech I: Dr. Luqman Rahman

Dr. Luqman Rahman is a highly qualified and experienced Medical Oncologist with an impressive academic background. He graduated from a medical college in 1999 and was ranked first among the top ten graduates. He completed his internship and then pursued a master’s degree from Nottingham University in the United Kingdom. He further specialized in Medical Oncology with two years of training at City Hospital in the UK.

Dr. Luqman went on to establish a specialized Medical Oncology unit for treating adult solid tumors at Nanakaly Hospital in Erbil city. He served as the head of the unit until January 2009, when he embarked on his MD PhD program in Cancer at Cancer Centrum in Karolinska Institute in Stockholm, Sweden.

Currently, he is working as a Consultant Oncologist at Nanakaly Hospital for Blood Diseases and Oncology and holds the position of Senior Lecturer at the College of Medicine, Hawler Medical University.

Keynote Speech II: Dr. Amin Malik Shah Abdul Majid, Founder of NatureCeuticals, Eman Research Ltd. Malaysia

Dr. Amin Malik Shah is a pharmacologist by training. He obtained his Ph.D. in University of New South Wales, Australia after graduating from University of Auckland, New Zealand.

Dr. Amin founded NatureCeuticals to further develop his research ideas into pharmaceuticals his research interest focuses on the development of drugs that target angiogenesis for the treatment of cancer. Many of his research activities in this field are centered towards natural products particularly into transforming herbs into pharmaceutical employing various manufacturing and formulation technologies.

Key Speaker III: Dr. Hassaan A. Rathore, PhD

Associate Professor of Pharmaceutical Sciences

College of Pharmacy, Qatar University

Dr. Hassaan A. Rathore obtained his doctorate from the University of Science, Malaysia (USM). He is a distinguished academic and researcher with a wide range of expertise in a variety of fields, such as Physiology, Pharmacology, Hypertension, Cardiovascular and Renal Pharmacy, and Medicinal Plants. His particular area of expertise is lung counter studies. Dr. Rathore’s academic accomplishments are noteworthy, as evidenced by: References: 1,879, h-index: 22 (overall), 17 (recent) i10-index: 39 (overall), 30 (recent)

Dr. Rathore is committed to the advancement of interdisciplinary research, the promotion of education, and the development of pharmaceutical sciences that have a global health impact in his capacity as an Associate Professor at Qatar University’s College of Pharmacy.

Speaker 1: Dr Suzan Hoshyar oncologist

Director of Breast Center Adjunct faculty at UKH

Dr. Suzan Hoshyar is a surgeon who is highly skilled in general and gastrointestinal surgeries. She is the Director of the Breast Centre, where she oversees the provision of specialized treatment and care for breast-related conditions. Furthermore, Dr Suzan is an Adjunct Faculty and Academic Staff Member at the University of Kurdistan Hewlêr (UKH), where she is actively engaged in medical education and clinical practice. She is expertise in breast surgery, gland surgery, and haemorrhoid treatment.

Speaker: 2 Dr. Fahad Abdulwahab Jameel

Hematopathologist, University of Duhok

AmrLab Medical Laboratories.